Kardium Announces Publication of PULSAR Pivotal Trial Results in JACC

Kardium Announces Publication of PULSAR Pivotal Trial Results in JACC

VANCOUVER, British Columbia -- Kardium Inc., an emerging leader in advanced solutions for atrial fibrillation, is proud to announce the publication of the PULSAR clinical trial results in the Journal of the American College of Cardiology (JACC). This landmark study evaluated the Globe® Pulsed Field System by Kardium for the treatment of paroxysmal atrial fibrillation (PAF).

Kardium unveils further pivotal trial results for Globe PFA system

Kardium has unveiled further results from the pivotal trial of its Globe Pulsed Field System, demonstrating the system’s success in pulmonary vein isolation (PVI) and paroxysmal atrial fibrillation (AFib) treatment.The post Kardium unveils further pivotal trial results for Globe PFA system appeared first on Clinical Trials Arena.

Kardium Announces Publication of PULSAR Pivotal Trial Results in JACC - Life Sciences British Columbia

Kardium Inc. announced the publication of the PULSAR clinical trial results in the Journal of the American College of Cardiology (JACC).

Kardium Publishes Trial Results for Globe Pulsed Field System

This study evaluated the Globe Pulsed Field System by Kardium for the treatment of paroxysmal atrial fibrillation.